Courier Health Raises $50M Series B to Optimize Patient Experience for Biopharma Companies

Healthcare doesn’t break loudly, it erodes quietly. Delays stack. Patients stall. What should be a straight line from diagnosis to therapy turns into a maze with no map and too many exits. Courier Health looked at that maze and decided it was not inevitable, it was fixable.

Now the market just co-signed that thesis with $50M in fresh Series B capital, led by Oak HC/FT with Norwest and Work-Bench doubling down. Not a polite nod either. This is conviction capital walking into a messy room and saying, fix it properly.

Big respect to Danny Sigurdson for building this with a level of focus most people only pretend to have. Founder and CEO, yes, but more importantly someone who picked a brutal problem and did not blink. Alongside him, Michaela Lehr (CFO) and John Eckhart (CTO) are helping turn that vision into something operational, something that actually scales without breaking under pressure. Congrats to the entire Courier Health team for turning friction into a product people actually need.

Courier Health is not playing in the shallow end. They built a patient experience platform and CRM specifically for biopharma, not retrofitted, not stitched together. Purpose built. From diagnosis to therapy initiation to adherence, they are wiring together a journey that historically felt like a relay race where nobody practiced the handoff.

And the numbers tell on everybody. 7x team efficiency. 67% reduction in time to start. 15%+ lift in patient starts. That is not marketing fluff, that is operational gravity shifting. When you compress time in healthcare, you are not just saving money, you are changing outcomes.

The play here is discipline. They did not chase 10 markets. They went deep into one of the most complex corners of healthcare, chronic and rare diseases, and built for the people actually doing the work. Field access, patient services, commercial ops. The folks in the trenches finally get a system that speaks their language.

Now layer in intelligence where it counts, inside the workflow, inside the moments that decide whether a patient moves forward or falls off. Connecting fragmented data, surfacing what matters, nudging teams before patients slip through the cracks. That is where this gets interesting. Not louder, just sharper.

At least $66.5M raised to date and this round is about acceleration. More product, deeper intelligence, wider reach across biopharma. The kind of scaling that rewards companies who already know exactly who they are.

Courier Health is not delivering packages, they are delivering continuity in a system that has been anything but continuous. And in healthcare, continuity is everything.